Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-anesthetic esketamine for early postoperative cognitive function and analgesia in elderly laparoscopic gastrointestinal surgery
ChiCTR2200064720Phase 4Recruiting
- Sponsor
- Quanzhou First Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in post-operative cognitive decline (POCD) and postoperative pain (2 arms), sponsored by Quanzhou First Hospital. Primary endpoint: Montreal Cognitive Assessment score. Started Oct 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
post-operative cognitive decline (POCD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2200064720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064720.